Drug Shortage Report for CAVERJECT STERILE POWDER

Last updated on 2022-06-23 History
Report ID 154018
Drug Identification Number 02215756
Brand name CAVERJECT STERILE POWDER
Common or Proper name CAVERJECT
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) ALPROSTADIL
Strength(s) 20MCG
Dosage form(s) POWDER FOR SOLUTION LIQUID KIT
Route of administration INTRACAVERNOSAL INTRACAVERNOSAL
Packaging size 5 X 20MCG
ATC code G04BE
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2022-03-25
Actual start date 2022-03-02
Estimated end date 2022-10-31
Actual end date
Shortage status Actual shortage
Updated date 2022-06-23
Company comments Currently under preventive allocation
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-06-23 French Compare
v10 2022-06-23 English Compare
v9 2022-06-06 French Compare
v8 2022-06-06 English Compare
v7 2022-03-14 French Compare
v6 2022-03-14 English Compare
v5 2022-03-03 English Compare
v4 2022-03-02 French Compare
v3 2022-03-02 English Compare
v2 2022-02-01 French Compare
v1 2022-02-01 English Compare

Showing 1 to 11 of 11